Travere Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Travere Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About TVTX
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases.
CEOEric M. Dube
CEOEric M. Dube
Employees385
Employees385
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2008
Founded2008
Employees385
Employees385
TVTX Key Statistics
Market cap3.13B
Market cap3.13B
Price-Earnings ratio-32.27
Price-Earnings ratio-32.27
Dividend yield—
Dividend yield—
Average volume1.46M
Average volume1.46M
High today$35.59
High today$35.59
Low today$34.52
Low today$34.52
Open price$35.32
Open price$35.32
Volume1.57M
Volume1.57M
52 Week high$37.50
52 Week high$37.50
52 Week low$12.91
52 Week low$12.91
Stock Snapshot
Travere Therapeutics(TVTX) stock is priced at $35.05, giving the company a market capitalization of 3.13B. It carries a P/E multiple of -32.27.
On 2025-12-08, Travere Therapeutics(TVTX) stock moved within a range of $34.52 to $35.59. With shares now at $35.05, the stock is trading +1.5% above its intraday low and -1.5% below the session's peak.
Trading volume for Travere Therapeutics(TVTX) stock has reached 1.57M, versus its average volume of 1.46M.
The stock's 52-week range extends from a low of $12.91 to a high of $37.50.
The stock's 52-week range extends from a low of $12.91 to a high of $37.50.
Analyst ratings
87%
of 15 ratingsBuy
86.7%
Hold
13.3%
Sell
0%
People also own
Based on the portfolios of people who own TVTX. This list is generated using Robinhood data, and it’s not a recommendation.